With no cure in sight, any new approval ushers in hope, including with an agent like Leqembi that slowed progression of the disease an average of 27% in research.
from WebMD Health https://www.webmd.com/alzheimers/news/20230707/approval-of-alzheimers-drug-brings-home-some-safety-concerns?src=RSS_PUBLIC
0 Comments:
Post a Comment